Modular Prosthetic Replacement for Bone Tumors in the Hip
Author Information
Author(s): Chandrasekar Coonoor R, Grimer Robert J, Carter Simon R, Tillman Roger M, Abudu Adesegun T
Primary Institution: Royal Orthopaedic Hospital, Birmingham, UK
Hypothesis
The study aims to assess the clinical and functional outcomes following modular tumour prosthesis reconstruction of the proximal femur in patients with metastatic tumours.
Conclusion
The METS modular tumour prosthesis for the proximal femur provides versatility, low implant-related complications, and acceptable function lasting the lifetime of patients with metastatic tumours.
Supporting Evidence
- The estimated five-year implant survival was 83.1%.
- The mean TESS score was 64%.
- The limb salvage rate was 99%.
Takeaway
Doctors can use special hip implants to help people with cancer in their bones, and these implants work well for a long time.
Methodology
The study analyzed 100 consecutive patients who underwent modular tumour prosthetic reconstruction of the proximal femur for metastases, assessing survival, local control, implant survival, and complications.
Limitations
The study is limited by its retrospective nature and the follow-up duration of 15.9 months.
Participant Demographics
45 male and 55 female patients with a mean age of 60.2 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website